Johnson & Johnson surpassed earnings expectations with strong sales, but it faces challenges ahead due to patent expirations.

Expects more pronounced impact from newly launched products as the year progresses. STELARA biosimilar competition to ...

"As a healthcare company with a disease-centric approach, we are improving the standard of care in a broad range of diseases with high unmet need, including multiple myeloma, lung cancer, inflammatory ...

Johnson & Johnson (JNJ) is currently at $142.83, down $5.32 or 3.59% --Would be lowest close since Jan. 10, 2025, when it closed at $142.06 --On pace for largest percent decrease since July 31, 2023, ...

How far would you go to live a longer, healthier life? For tech entrepreneur Bryan Johnson, the answer is “as far as possible.” After spending the day living like Johnson, I have my limits. On ...

Cheesemakers have long used the term “natural cheese” to distinguish products that use basic ingredients and are made ...

How far would you go to live a longer, healthier life? For tech entrepreneur Bryan Johnson, the answer is “as far as possible.” After spending the day living like Johnson, I have my limits. On ...

From using sites like Poshmark to listing items on Facebook Marketplace or the OfferUp app, determined entrepreneurs can earn ...

The Cottage Hill Dairy is in Beavercreek, and they’re expecting more than 100 goat kids this month. Each goat has a name and ...

Johnson & Johnson (NYSE: JNJ) shares dipped slightly before hours today on fourth-quarter results that topped the consensus ...

Biodexa Strengthens Management Team Appointment of Dr Gary A. Shangold as Chief Medical Officer Biodexa Pharmaceuticals PLC ("Biodexa" or "the Company"), (Nasdaq: BDRX), a clinical ...

As Stelara biosimilars chip away at sales in Europe and off-brand rivals start to grace the stage in the U.S., Johnson & ...